Control of the bovine estrous cycle with melengestrol acetate (MGA): a review

Expanded use of artificial insemination in the beef cattle industry depends on successful application of treatments designed to synchronize estrus. Regulation of estrous cycles is associated with control of the corpus luteum (CL), whose life span and secretory activity are subject to trophic and lytic mechanisms. The advantages of melengestrol acetate (MGA) in estrous synchronization incorporate ease of administration, lower cost relative to other estrous synchronization products, and potential for use to induce estrus in prepubertal heifers. Treatments first designed to synchronize estrous cycles of normally cycling heifers by feeding MGA were imposed daily for 14 to 18 d at levels of .5 to 1 mg. The minimal daily effective dose required to inhibit ovulation was .42 mg. Longer feeding periods of MGA were associated with low fertility at the first synchronized estrus, but at the second estrus, conception was normal. Low fertility at the synchronized estrus resulted in development of alternative treatment practices, which combined feeding of MGA with injections or implants of estradiol-17 beta, estradiol cypionate, luteinizing hormone, human chorionic gonadotropin, pregnant mare serum gonadotropin, or oxytocin. Estrus was synchronized after MGA and estradiol-17 beta or estradiol cypionate treatments, but fertility was low. Short-term feeding of MGA (5 to 7 d) combined with prostaglandin F2 alpha or its analogs (PGF) on the last day of MGA reduced fertility at the synchronized estrus. The reduced conception at first service occurred in animals that began treatment after d 12 of the estrous cycle. However, feeding MGA for 14 d and then injecting PGF 17 d later avoided problems with reduced conception. Fertility of animals after this treatment was similar to that of contemporaries synchronized with Syncro-Mate-B. However, the length of the treatment period creates a need for increased management and may extend management beyond practical limits. Further research is warranted to address problems associated with reduced fertility after short-term treatment with MGA.     

Histologic features of mammary carcinomas in zoo felids treated with melengestrol acetate (MGA) contraceptives

Melengestrol acetate (MGA), a potent synthetic progestin, has been used as a contraceptive in zoo felids since 1975. Mammary gland carcinomas have been linked to MGA treatment in zoo felids, but the histologic features of these tumors and steroid receptor expression have not been described. Zoo felid mammary tumors were requested from participating zoos from 1986 through 1998, and 31 mammary carcinomas from 28 MGA-treated and 3 untreated felids were received. The carcinomas were evaluated on the basis of histologic pattern, tumor grade, and occurrence of metastasis; then features of the tumors were compared to determine if carcinomas in MGA-treated felids differed from those that occur spontaneously. Estrogen- and progesterone-receptor expression was evaluated in 17 of the 31 carcinomas. Of the 31 tumors, 22 (70.9%) had multiple histologic patterns, 29 (93.5%) were high grade, and 28 (90.3%) had metastasized. Within tumors, the tubulopapillary pattern was most common (87.1%, n = 27); solid (61.3%, n = 19), cribriform (38.7%, n = 12), and comedone (25.8%, n = 8) patterns were less common; and the mucinous (3.2%, n = 1) pattern was rare. Both MGA-treated and untreated zoo felids had similar patterns and grades of mammary gland cancer as well as prevalence of metastasis. These results indicate that mammary carcinomas in zoo felids are high grade with a predominant tubulopapillary pattern and aggressive behavior. Five of 17 carcinomas expressed progesterone receptors, and 1 of 17 expressed estrogen receptors. Although more zoo felids with cancer had been exposed to MGA in this study, mammary carcinomas were similar in appearance and behavior in untreated and MGA-treated zoo felids. The association of MGA with the development of malignant mammary gland tumors should be considered when using this contraceptive in zoo felids.     

Effect of storage on quality traits of the semimembranosus muscle of farmed fallow deer (Dama dama) bucks and does

A total of 12 farmed fallow deer bucks and 12 does aged 31–32 months were included in a study on the effect of storage in vacuum packaging on the functionality of venison of the Semimembranosus muscle. All the analyzed meat quality traits were not affected by sex. The storage of meat in vacuum led to: an increase of pH (by 0.13 units; P = 0.001), L* (by 1.85 units; P = 0.002), a* (by 1.15 units; P = 0.013) and chroma (by 1.16 units; P = 0.016), a decrease of free water (by 6.62 percentage points (p.p.); P = 0.001) and water‐holding capacity (cm²) (by 29.61%; P = 0.001), and the increase of dry matter content (by 0.67 p.p.; P = 0.001). The results indicate that the chilled storage of venison caused the stabilization of pH and color, improvement of water‐holding capacity, with no negative effect on the proximate chemical composition. The quality of deer meat obtained from does and bucks was similar.     

Effects of 21-day treatment with melengestrol acetate (MGA) with or without subsequent prostaglandin F2 alpha on synchronization of estrus and fertility in beef cattle

Beef cattle were treated to synchronize estrus using one of three procedures, and effects on subsequent endocrine responses and fertility were studied. Procedures were 1) feeding .5 mg.head-1.d-1 of melengestrol acetate (MGA) for 21 d (M), 2) feeding .5 mg.head-1.d-1 of melengestrol acetate for 21 d followed 14 d later by a single injection of prostaglandin F2 alpha (M + P) and 3) two injections of prostaglandin (PGF) 14 d apart (P). In Exp. 1, 94 beef cows were assigned to be artificially inseminated 12 h after detection of estrus. Procedures for synchronizing estrus did not affect the proportion of cows observed in estrus within 7 d (mean = 70.2%). However, conception rate of cows treated with MGA alone was lower (P less than .01) than that of cows treated with PGF alone (31.8 vs 78.3%). The conception rate of cows in the M + P group was intermediate (57.1%) but greater than that of cows treated with MGA alone (P less than .10). In Exp. 2, 18 heifers were observed for estrus four times daily and bled daily from 1 wk before predicted estrus until second estrus or 35 d post-treatment. Heifers treated with MGA alone maintained lower concentrations of progesterone and higher concentrations of estradiol-17 beta before first estrus than heifers treated with MGA and PGF or PGF alone (P less than .01). Conception rate following insemination was lower after long-term feeding of MGA than after two injections of PGF. Delaying insemination until after a PGF-shortened cycle 14 d after MGA resulted in an intermediate conception rate.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of melengestrol acetate on development of 3-methylindole-induced pulmonary edema and emphysema in sheep.

The involvement of melengestrol acetate (MGA) in susceptibility to developing pulmonary edema and emphysema following oral administration of 3-methylindole (3MI) was investigated using 10 Suffolk ewes receiving 0 or 0.15 mg of MGA daily (n = 5). Blood, urine and ruminal fluid were collected immediately prior to 3MI dosing (0.2 g/kg BW) and 1, 2, 3, 4, 5, 6, 12 and 24 h (blood); 3, 6, 9, 12 and 15 h (urine) and 1, 2, 3 and 12 h (ruminal fluid) afterward. Ewes receiving MGA experienced earlier (P < 0.05) onset of respiratory distress than the control ewes (2.5 vs 4 h), and upon euthanasia at 96 h, their lung weight relative to body weight tended (P < 0.10) to be lower. Ruminal 3MI concentrations did not differ between treatments (P > 0.05). Ewes receiving MGA had higher (P < 0.05) concentrations of 3MI metabolites in plasma prior to dosing than did control ewes, and these values tended to remain higher throughout the sampling period. Immunoreactivity assays indicated more pneumotoxin present in the lungs of MGA-treated ewes than controls. Lung damage was apparently more acute and accelerated in the MGA-treated ewes than in the controls. Urinary 3MI mercapturate concentrations differed (control > MGA-treated, P < 0.05) at 9, 12, and 15 h, but this difference was not apparent when urinary production (as estimated by creatinine concentration) was considered. The implications of these findings for MGA-treated feedlot heifers are currently under investigation.     

Rearing performance of farmed fallow deer (Dania dama)

The ability of fallow does to rear fawns to weaning age was examined in a group of 243 adult does of known age (Group 1) and 509 adult does of unknown age (Group 2). All does had between 1 and 8 opportunities to rear fawns. There was an increasing proportion of does that failed to rear a fawn to weaning age as the number of rearing opportunities increased, although most does (93.6%) only failed on one occasion. A small percentage of does in groups 1 and 2 failed repeatedly to rear fawns to weaning. At slaughter, the presumed causes of failure in chronic non-breeders included pyometron, cystic ovaries, cervical cysts, a vulval neoplasm and salpingitis. The overall rearing success of both groups of deer was 82.4% and there was no consistent pattern of rearing failure relating to parity or previous rearing history.     

Causes of perinatal mortality in farmed fallow deer (Dama dama)

The causes of perinatal mortality in farmed fallow deer in the Camden region of New South Wales were determined between 1982 and 1987. The results of 144 necropsies on fawns showed that ante-parturient and parturient deaths occurred in 33 (22.9%) of cases, with post-parturient deaths accounting for 99 (69.8%), and undiagnosed causes the remaining 12 (8.3%). The most common cause of post-parturient death (43.1%) was exposure/starvation of fawns that had birthweights lower than the average for surviving fawns on these same farms (3.01 kg and 4.12 kg, respectively). These results provide good evidence of the correlation between low birthweight and perinatal mortality in fallow deer on Australian deer farms.     

Effect of Supplementation with Agro-industrial By-products and Khat (Catha edulis) leftovers on testicular growth and sperm production in Ogaden bucks

The aim of this study was to characterize growth and sperm production parameters in Ogaden bucks fed a basal diet of hay and supplemented with agro-industrial by-products and Khat leftovers in Ethiopia. Thirty-five bucks with a mean (+/-SD) initial live body weight (BW) of 15.5 +/- 1.5 kg were randomly assigned to one of four dietary treatments for a period of 13 weeks. Treatments consisted of native hay fed ad libitum (control; C), native hay supplemented with a 1% of BW agro-industrial by-products (treatment 1; T1), native hay supplemented with Khat (Catha edulis) leftovers at a rate of 1% of BW (treatment 2; T2) and Khat leftovers fed ad libitum (treatment 3; T3). Bucks fed on T1-T3 had higher BW, body condition score, scrotal circumference (SC), testicular width and testicular length, compared to controls (P < 0.05). Also, bucks in T1-T3 had higher sperm progressive motility, sperm concentration per ml and total number of spermatozoa per ejaculate compared to controls (P < 0.05). Between treatments, bucks in T3 recorded the highest BW (17.2 +/- 0.16) and testicular size (21.1 +/- 0.17 cm). Both testicular and epididymal weight and dimensions were significantly affected (P < 0.05) by supplementation compared to controls. Testicular size was positively correlated to live BW (r = 0.53, P < 0.001). SC was positively correlated with ejaculate volume (r = 0.37, P < 0.001), sperm mass activity (r = 0.65, P < 0.001) and individual sperm progressive motility (r = 0.40; P < 0.001). Supplementation with Khat leftovers induced the highest improvement in live BW, testicular size, semen production and sperm motility in Ogaden bucks and can possibly be considered as a feed supplement to enhance goat production under smallholder livestock farming system in Ethiopia.     

Effect of zeranol on sexual development of crossbred bulls

Three groups of 1/2 Simmental X 1/4 Brahman X 1/4 Hereford bull calves were used during two different years to study effects of zeranol on sexual development. At 154 d of age, half the calves were implanted with 36 mg zeranol and half, not implanted, served as controls. Implanted calves were reimplanted at 90-d intervals throughout the trial (9 mo) each year. Trial 1 was conducted with 24 calves and Trial 2 was conducted the following year with 10 bulls. Twenty-four days after weaning (200 d of age) and at 28-d intervals thereafter, bulls in drylot in Trial 1 were weighted, scrotal circumference (SC) was measured and an ejaculate of semen was collected by electroejaculation to determine puberty. At these times, bulls were given 200 micrograms of GnRH i.m. and blood was collected at 0, 1, 2, 3, 4 and 5 h after GnRH. Serum concentrations of LH and testosterone (TEST) were determined. At slaughter, testis weight, length and circumference and pubertal status were recorded. Bulls implanted with zeranol had smaller SC than control bulls during the entire 9-mo period (P less than .0001). More control bulls reached puberty than did implanted bulls (82.4 vs 23.5%, respectively; P less than .001). Control bulls had larger testis measurements at slaughter (P less than .0001). Implants did not alter total weight gain or ADG (P greater than .10).(ABSTRACT TRUNCATED AT 250 WORDS)     

The reproductive performance of farmed fallow deer (Dama dama) in New South Wales

Observations on the reproductive performance of fallow deer on 47 farms in New South Wales were made over 6 consecutive years. The minimum fawning rate for does varied significantly (p less than 0.001) between years, the corresponding fawning percentages varying from 75.0% to 96.4%, with an overall mean of 88.8%. The weaning rate also varied significantly (p less than 0.001) between years, the corresponding percentages varying from 65.0% to 89.1% with a mean over 6 years of 81.4%. Weaning rates were low given the known high fertility of fallow deer. The ratio of male to female fawns at weaning varied significantly (p less than 0.05) between years, although the ratio was exactly 1:1 for all births recorded over the 6-year period. The mean birthweights for female and male fawns were 4.01 kg +/- 0.61 (n = 330) and 4.23 kg +/- 0.72 (n = 348) respectively. Mean birthweights varied significantly (p less than 0.001) between the sexes and between years. There was a greater difference between birthweights of male and female fawns in years with higher mean fawn birthweight. Fawn birthweights generally approximated 10% of the pre-rut weight of their mother. Handling of newborn fawns for tagging and weighting did not increase the chance of mismothering and rejection. The mean weaning weight for doe fawns and buck fawns over 6 years was 18.7 kg (n = 227) and 21.2 kg (n = 231) respectively, with a mean birth to weaning interval of 108.4 +/- 4.89 (n = 458). Growth rates of male fawns from birth to weaning were significantly higher (p less than 0.01) than for female fawns, and the growth rates of fawns were significantly different (p less than 0.01) between years.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of dietary melengestrol acetate on the incidence of acute interstitial pneumonia in feedlot heifers

Over a 3-y period, 906,000 cattle were monitored in 23 feedlots in southern Alberta for symptoms of acute interstitial pneumonia (AIP). Plasma, urine, and lung tissue were collected at slaughter from 299 animals clinically diagnosed with AIP and from 156 healthy penmates and analyzed for 3-methylindole (3MI) derivatives and reduced glutathione concentration. From each animal, the left lung was subsampled for histologic examination. Concentrations of glutathione in lung tissue were reduced (P < 0.001) in animals showing clinical symptoms of AIP as compared with their asymptomatic penmates. Animals histologically confirmed as having AIP had higher levels of 3MI protein adducts in blood and lung tissue (P < 0.05) than did emergency-slaughtered animals without AIP. Within feedlots, where pens of heifers were fed either a standard dosage of melengestrol acetate (MGA) or none, the rate of death attributable to AIP was similar between treatment groups, but emergency slaughter after clinical diagnosis of AIP was done 3.2 times more often (P < 0.001) in the MGA-fed heifers than in the group not fed MGA. Use of MGA did not influence glutathione concentration. As growth performance of heifers given steroidal implants may not be improved by feeding MGA, the most cost-effective method of reducing the incidence of AIP-related emergency slaughter in feedlot heifers may be to eliminate MGA from the diet.     

Blood coagulation parameters in clinically normal intensively farmed red deer (Cervus elaphus) and fallow deer (Dama dama)

Reference ranges for five parameters of blood coagulation were established in clinically normal farmed fallow deer (Dama dama) and red deer (Cervus elaphus). Storage of plasma at -15 degrees C resulted in small increases in activated partial thromboplastin time (APTT) for both species, and in the one stage prothrombin time (OSPT) of fallow deer, between days 1 and 30. These times were then stable between days 30 and 60. The fibrinogen levels of fallow deer plasma showed a small apparent increase over 60 days. These storage artefacts were not of sufficient magnitude to preclude the use of such plasma for diagnostic purposes although they could limit its use in research. Levels of fibrin/fibrinogen degradation products (FDP) were not affected by storage at -15 degrees C. Rabbit brain thromboplastin appeared adequate for OSPT determination in both species. The activated clotting time (ACT) is recommended as a field test for screening the intrinsic and common pathways of blood coagulation in deer.     

The use of a progesterone-releasing device (CIDR-B) or melengestrol acetate with GnRH,LH, or estradiol benzoate for fixed-time AI in beef heifers

The objective of this experiment was to compare two progestins and three treatments for synchronizing follicular wave emergence and ovulation in protocols for fixed-time AI in beef heifers. On d 0 (beginning of the experiment), Angus and Angus-Simmental cross beef heifers at random stages of the estrous cycle either received a CIDR-B device (n = 257) or were started on 0.5 mg x anima(-1) x d(-1) melengestrol acetate (MGA; n = 246) and were randomly assigned to receive i.m. injections of 100 microg GnRH, 12.5 mg porcine LH (pLH), or 2 mg estradiol benzoate (EB) and 50 mg progesterone (P4). The last feeding of MGA was given on d 6 and on d 7, CIDR-B devices were removed and all heifers received 500 microg cloprostenol (PG). Consistent with their treatment groups on d 0, heifers were given either 100 microg GnRH or 12.5 mg pLH 48 h after PG (and were concurrently inseminated) or 1 mg EB 24 h after PG and were inseminated 28 h later (52 h after PGF). Estrus rate (combined for both progestins) in heifers receiving EB (92.0%) was greater (P < 0.05) than that in heifers receiving GnRH and pLH (combined) and a CIDR-B device (62.9%) or MGA (34.3%). Although the mean interval from PG treatment to estrus did not differ among groups (overall, 47.8 h; P = 0.85), it was less variable (P < 0.01) in MGA-fed heifers (SD = 2.5 h) than in CIDR-B-treated heifers (SD = 8.1 h). Pregnancy rates (determined by ultrasonography approximately 30 d after AI) did not differ (P = 0.30) among the six treatment groups (average, 58.0%; range, 52.5 to 65.0%). Although fixed-time AI was done, pregnancy rates were greater in heifers detected in estrus than in those not detected in estrus (62.6 vs 51.9%; P < 0.05). In conclusion, GnRH, pLH, or EB treatment in combination with a CIDR-B device or MGA effectively synchronized ovulation-for fixed-time AI, resulting in acceptable pregnancy rates in beef heifers.